Eyevance Pharmaceuticals Acquires TOBRADEX(R) ST and NATACYN(R)

Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Company executes its 7th strategic transaction in two years FORT WORTH, Texas, Oct. 16, 2019 -- (Healthcare Sales & Marketing Ne... Biopharmaceuticals, Ophthalmology, Acquisitions Eyevance Pharmaceuticals, TOBRADEX, tobramycin, NATACYN, natamycin, Novartis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news